Skip to content
  • About the Centre
  • Research
    • Research Areas
      • Molecular Triggers of Migraine Pain
      • Modulators of Migraine Pain
      • Triggering Migraine Aura
      • The Role of Neuroinflammation
    • Research Projects
  • Staff and Researchers
  • Publications
  • News
    • News
    • LinkedIn Feed
  • About the Centre
  • Research
    • Research Areas
      • Molecular Triggers of Migraine Pain
      • Modulators of Migraine Pain
      • Triggering Migraine Aura
      • The Role of Neuroinflammation
    • Research Projects
  • Staff and Researchers
  • Publications
  • News
    • News
    • LinkedIn Feed

Home Publications PET and fMRI insights into experimentally-induced premonitory symptoms in migraine: A systematic review

  • Scientific Articles
  • First published March 3, 2026

PET and fMRI insights into experimentally-induced premonitory symptoms in migraine: A systematic review

Messoud Ashina

Home Publications PET and fMRI insights into experimentally-induced premonitory symptoms in migraine: A systematic review

Access to document

10.1177/00315125261420694

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Other files & links

Link to publication in Scopus

Abstract

Background

Migraine attacks are believed to unfold through discrete but interrelated phases, among which the premonitory phase has garnered increasing attention. This early phase, occurring hours to days before pain onset, might reflect neurobiological processes that promote subsequent headache generation. Neuroimaging of experimentally induced attacks enables controlled investigation of the brain mechanisms underlying these early symptoms. This systematic review synthesizes and critically appraises current neuroimaging evidence on the experimentally induced premonitory phase in individuals with migraine.

Methods

A systematic literature search of MEDLINE and Embase was performed from database inception through June 1, 2025, using predefined terms related to migraine and premonitory symptoms. Studies were eligible if they reported original neuroimaging findings on experimentally induced migraine attacks and specifically addressed the premonitory phase. Two independent reviewers screened all titles, abstracts, and full-text articles and extracted relevant data. Due to methodological heterogeneity in study design, a narrative synthesis was applied to summarize findings and assess the consistency of reported brain activity patterns across included studies.

Results

Seven studies met the inclusion criteria, all of which used glyceryl trinitrate to induce migraine attacks and applied either positron emission tomography or magnetic resonance imaging to assess brain changes. Across studies, reported alterations in cerebral perfusion and functional connectivity—used as surrogates for neural activity—during the premonitory phase were inconsistent and lacked replication. While some investigations suggested involvement of the thalamus and pons, these findings were derived exclusively from exploratory or uncorrected analyses. Hypothalamic involvement—a hypothesized migraine generator—was only sporadically observed, and reproducibility not investigated. The inconsistencies across studies likely reflect small sample sizes (ranging from 5 to 21 participants), suboptimal definitions of the premonitory phase, absence of appropriate controls, and unconventional use of neuroimaging statistics.

Conclusions

Neuroimaging studies investigating the experimentally induced premonitory phase of migraine have largely produced inconsistent findings, likely due to small sample sizes, non-standardized symptom definitions, and exploratory imaging analyses lacking statistical rigor. Current evidence offers limited support for specific neural correlates of this phase, and its translatability to spontaneous migraine remains uncertain. To improve interpretability and clinical relevance, future research should prioritize standardized definitions, adequate control groups, and use of appropriate neuroimaging statistics.

The Center for Discoveries in Migraine (CDM) is a research center of excellence dedicated to advancing the understanding of migraine mechanisms and developing targeted treatments through interdisciplinary and international collaboration.

Funded by the Danish National Research Foundation (DNRF)

Contact

  • Valdemar Hansens Vej 5, indgang 1A, 2600 Glostrup
  • Tel.: +45 41 91 88 33
  • Mail: info@discovermigraine.dk
  • VAT: DK29190623

Quick links

  • Home
  • About the Centre
  • Research
  • Staff and Researchers
  • Publications
  • News and Activities
  • Contact
  • Home
  • About the Centre
  • Research
  • Staff and Researchers
  • Publications
  • News and Activities
  • Contact

© 2026 Center for Discoveries in Migraine

  • Privacy Policy
  • Cookie Policy

Made by Aveo

Search

PET and fMRI insights into experimentally-induced premonitory symptoms in migraine: A systematic review

Menu

Home
About the Centre
Research
Staff and Researchers
Publications
News and Activities
Contact
Research Areas
Research Projects
Molecular Triggers of Migraine Pain
Modulators of Migraine Pain
Triggering Migraine Aura
The Role of Neuroinflammation
News
Events
LinkedIn Feed